Zanqueta Coelho Peev, Cristiane

Insider profile

Performance

Overall performance
0.7

Performance over holding periods
0.7
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Zanqueta Coelho Peev, Cristiane's trades of Knight Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
105.86
Quantity 35,960 +47.3%
Value CA$449,649
Transaction date
Planned purchase
Price
134.44
Quantity 10,931 +9.0%
Value CA$4,198,911
Transaction date
Planned purchase
Price
464.68
Quantity 58,240 -20.5%
Value CA$2,539,512
Transaction date
Planned purchase
Price
5.90
Quantity 262
Value CA$1,546
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-30 2026-03-26 S Sale
35,960 +47.3%
105.86
CA$449,649
35,960 +47.3% 105.86 CA$449,649
2026-03-20 2026-03-15 PP Planned purchase
10,931 +9.0%
134.44
CA$4,198,911
10,931 +9.0% 134.44 CA$4,198,911
2025-09-18 2025-09-15 PP Planned purchase
58,240 -20.5%
464.68
CA$2,539,512
58,240 -20.5% 464.68 CA$2,539,512
2024-09-18 2024-09-15 PP Planned purchase
262
5.90
CA$1,546
262 5.90 CA$1,546